Nipro (FRA:5FA) Cyclically Adjusted PS Ratio: (As of Sep. 21, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:5FA Nipro Corp FRA:5FA
71 GF Score
Price €7.85
GF Value €7.85
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Nipro Cyclically Adjusted PS Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Nipro  (FRA:5FA) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Nipro Cyclically Adjusted PS Ratio Related Terms


Nipro Cyclically Adjusted PS Ratio Historical Data

* Premium members only.

The historical data trend for Nipro's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nipro Cyclically Adjusted PS Ratio Chart

Nipro Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.42 0.36 0.35 0.39 0.38

Nipro Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.34 0.39 0.36 0.38 0.37

FRA:5FA vs ISRG, BDX, RMD: Cyclically Adjusted PS Ratio Comparison

For the Medical Instruments & Supplies subindustry, Nipro's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nipro Cyclically Adjusted PS Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Nipro's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Nipro's Cyclically Adjusted PS Ratio falls into.


FRA:5FA
71GF Score
Nipro Corp FRA:5FA
Cyclically Adjusted PS Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nipro Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Nipro's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, Nipro's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=4.987/113.6000*113.6000
=4.987

Current CPI (Jun. 2026) = 113.6000.

Nipro Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 4.153 98.000 4.814
201612 4.236 98.400 4.890
201703 4.451 98.100 5.154
201706 4.173 98.500 4.813
201709 3.949 98.800 4.541
201712 4.348 99.400 4.969
201803 4.584 99.200 5.249
201806 4.325 99.200 4.953
201809 4.443 99.900 5.052
201812 4.886 99.700 5.567
201903 4.679 99.700 5.331
201906 4.931 99.800 5.613
201909 5.250 100.100 5.958
201912 5.259 100.500 5.945
202003 5.403 100.300 6.119
202006 5.104 99.900 5.804
202009 5.071 99.900 5.766
202012 5.294 99.300 6.056
202103 5.492 99.900 6.245
202106 5.488 99.500 6.266
202109 5.834 100.100 6.621
202112 5.272 100.100 5.983
202203 5.032 101.100 5.654
202206 5.031 101.800 5.614
202209 5.165 103.100 5.691
202212 5.498 104.100 6.000
202303 5.995 104.400 6.523
202306 5.108 105.200 5.516
202309 5.018 106.200 5.368
202312 5.236 106.800 5.569
202403 5.618 107.200 5.953
202406 4.938 108.200 5.184
202409 5.970 108.900 6.228
202412 5.592 110.700 5.738
202503 6.319 111.100 6.461
202506 5.279 111.700 5.369
202509 4.987 112.000 5.058
202512 5.148 113.000 5.175
202603 5.786 112.700 5.832
202606 4.987 113.600 4.987

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Nipro (FRA:5FA) Overvalued in 2026?

Based on GuruFocus' analysis, Nipro stock appears to be undervalued. The current stock price of €7.85 is trading 0% below its estimated GF Value™ of €7.85. GuruFocus considers Nipro to be Fairly Valued.

Key valuation signals for FRA:5FA:

  • Cyclically Adjusted PS Ratio:
  • GF Value™: €7.85 vs. price of €7.85 (0% below fair value)
  • GF Score™: 71/100 with 6 warning signs

No single metric tells the full story. See the FRA:5FA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Nipro Business Description

Other Exchanges 8086:Japan
Address 3-9-3 Honjo-Nishi Kita-ku, Osaka, JPN, 531-8510
Nipro Corp develops medical devices, most of which are related to dialysis and artificial organs. The firm operates in four segments: medical, pharmaceutical, glass, and other. The medical segment contributes the majority of revenue. It sells products related to injections, infusions, artificial organs, and cell cultures, as well as medical equipment for renal treatment, diabetes, and generic drugs. Renal products contribute the largest proportion of sales within the medical segment. The pharmaceutical segment manufactures pharmaceuticals, including oral drugs and injectables, which are supplied to pharmaceutical companies in Japan. The glass business sells glass products used for medical applications, such as vials and syringes. Nipro generates the majority of its revenue in Japan.
71GF Score

Get the complete analysis for FRA:5FA

Cyclically Adjusted PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€7.85
Price
€7.85
GF Value